BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30415874)

  • 1. Characterization of somatostatin receptors (SSTRs) expression and antiproliferative effect of somatostatin analogues in aggressive thyroid cancers.
    Carmona Matos DM; Jang S; Hijaz B; Chang AW; Lloyd RV; Chen H; Jaskula-Sztul R
    Surgery; 2019 Jan; 165(1):64-68. PubMed ID: 30415874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines.
    Ain KB; Taylor KD; Tofiq S; Venkataraman G
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1857-62. PubMed ID: 9177396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of somatostatin receptors in human melanoma cell lines: effect of two different somatostatin analogues, octreotide and SOM230, on cell proliferation.
    Martinez-Alonso M; Llecha N; Mayorga ME; Sorolla A; Dolcet X; Sanmartin V; Abal L; Casanova JM; Baradad M; Yeramian A; Egido R; Puig S; Vilella R; Matias-Guiu X; Marti RM
    J Int Med Res; 2009; 37(6):1813-22. PubMed ID: 20146879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin receptor subtype expression in human thyroid tumours.
    Klagge A; Krause K; Schierle K; Steinert F; Dralle H; Fuhrer D
    Horm Metab Res; 2010 Apr; 42(4):237-40. PubMed ID: 20094970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin analogues inhibit cancer cell proliferation in an SSTR2-dependent manner via both cytostatic and cytotoxic pathways.
    Zou Y; Xiao X; Li Y; Zhou T
    Oncol Rep; 2009 Feb; 21(2):379-86. PubMed ID: 19148511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortistatin-14 inhibits cell proliferation of human thyroid carcinoma cell lines of both follicular and parafollicular origin.
    Cassoni P; Muccioli G; Marrocco T; Volante M; Allia E; Ghigo E; Deghenghi R; Papotti M
    J Endocrinol Invest; 2002 Apr; 25(4):362-8. PubMed ID: 12030609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acromegaly: correlation between expression of somatostatin receptor subtypes and response to octreotide-lar treatment.
    Casarini AP; Jallad RS; Pinto EM; Soares IC; Nonogaki S; Giannella-Neto D; Musolino NR; Alves VA; Bronstein MD
    Pituitary; 2009; 12(4):297-303. PubMed ID: 19330452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation of somatostatin receptor expression in human hepatocellular carcinoma tissue to serum alpha-fetoprotein concentration].
    Xie YM; Yan LN; Wei B; Guo MM; Tang CW
    Ai Zheng; 2007 Jul; 26(7):688-92. PubMed ID: 17626741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin receptor expression in adrenocortical tumors and effect of a new somatostatin analog SOM230 on hormone secretion in vitro and in ex vivo adrenal cells.
    Mariniello B; Finco I; Sartorato P; Patalano A; Iacobone M; Guzzardo V; Fassina A; Mantero F
    J Endocrinol Invest; 2011 Jun; 34(6):e131-8. PubMed ID: 21042045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of somatostatin and SSTR3 on proliferation and apoptosis of gastric cancer cells.
    Hu C; Yi C; Hao Z; Cao S; Li H; Shao X; Zhang J; Qiao T; Fan D
    Cancer Biol Ther; 2004 Aug; 3(8):726-30. PubMed ID: 15197339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of endothelial proliferation by the somatostatin analogue SOM230.
    Adams RL; Adams IP; Lindow SW; Atkin SL
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):431-6. PubMed ID: 15473874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octreotide stimulates somatostatin receptor-induced apoptosis of SW480 colon cancer cells by activation of glycogen synthase kinase-3β, A Wnt/β-catenin pathway modulator.
    Wang S; Bao Z; Liang QM; Long JW; Xiao ZS; Jiang ZJ; Liu B; Yang J; Long ZX
    Hepatogastroenterology; 2013 Oct; 60(127):1639-46. PubMed ID: 24634935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin receptor expression in thyroid disease.
    Atkinson H; England JA; Rafferty A; Jesudason V; Bedford K; Karsai L; Atkin SL
    Int J Exp Pathol; 2013 Jun; 94(3):226-9. PubMed ID: 23672766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential antiinflammatory and antinociceptive effects of the somatostatin analogs octreotide and pasireotide in a mouse model of immune-mediated arthritis.
    Imhof AK; Glück L; Gajda M; Lupp A; Bräuer R; Schaible HG; Schulz S
    Arthritis Rheum; 2011 Aug; 63(8):2352-62. PubMed ID: 21506098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology.
    Kumar U; Grigorakis SI; Watt HL; Sasi R; Snell L; Watson P; Chaudhari S
    Breast Cancer Res Treat; 2005 Jul; 92(2):175-86. PubMed ID: 15986128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of somatostatin analogue scintigraphy in the localization of recurrent medullary thyroid carcinoma.
    Bernà L; Chico A; Matías-Guiu X; Mato E; Catafau A; Alonso C; Mora J; Mauricio D; Rodríguez-Espinosa J; Marí C; Flotats A; Martín JC; Estorch M; Carrió I
    Eur J Nucl Med; 1998 Nov; 25(11):1482-8. PubMed ID: 9799343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human somatostatin receptor subtypes in acromegaly: distinct patterns of messenger ribonucleic acid expression and hormone suppression identify different tumoral phenotypes.
    Jaquet P; Saveanu A; Gunz G; Fina F; Zamora AJ; Grino M; Culler MD; Moreau JP; Enjalbert A; Ouafik LH
    J Clin Endocrinol Metab; 2000 Feb; 85(2):781-92. PubMed ID: 10690891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of somatostatin receptor subtypes and growth inhibition in human exocrine pancreatic cancers.
    Kikutsuji T; Harada M; Tashiro S; Ii S; Moritani M; Yamaoka T; Itakura M
    J Hepatobiliary Pancreat Surg; 2000; 7(5):496-503. PubMed ID: 11180877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for Somatostatin receptor 2 in thyroid tissue.
    Druckenthaner M; Schwarzer C; Ensinger C; Gabriel M; Prommegger R; Riccabona G; Decristoforo C
    Regul Pept; 2007 Jan; 138(1):32-9. PubMed ID: 16996150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors.
    Forssell-Aronsson EB; Nilsson O; Bejegård SA; Kölby L; Bernhardt P; Mölne J; Hashemi SH; Wängberg B; Tisell LE; Ahlman H
    J Nucl Med; 2000 Apr; 41(4):636-42. PubMed ID: 10768564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.